Lv41
530 积分 2021-08-09 加入
Increased reporting of accidental overdose with glucagon-like peptide-1 receptor agonists: a population-based study
5小时前
已完结
SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy
23天前
已完结
SGLT2 inhibitors protect podocytes in lupus nephritis
23天前
已完结
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by diuretic use: A FIDELITY analysis
28天前
已完结
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
1个月前
已完结
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
1个月前
已完结
Efficacy of lifestyle weight loss interventions on regression to normoglycemia and progression to type 2 diabetes in individuals with prediabetes: a systematic review and pairwise and dose-response meta-analyses
1个月前
已完结
Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials
1个月前
已完结
Cognitive disorders in diabetic patients
1个月前
已完结
Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial
1个月前
已完结
皖公网安备34019202002308
